Literature DB >> 34814314

PCa dynamics with neuroendocrine differentiation and distributed delay.

Leo Turner1, Andrew Burbanks1, Marianna Cerasuolo1.   

Abstract

Prostate cancer is the fifth most common cause of death from cancer, and the second most common diagnosed cancer in men. In the last few years many mathematical models have been proposed to describe the dynamics of prostate cancer under treatment. So far one of the major challenges has been the development of mathematical models that would represent in vivo conditions and therefore be suitable for clinical applications, while being mathematically treatable. In this paper, we take a step in this direction, by proposing a nonlinear distributed-delay dynamical system that explores neuroendocrine transdifferentiation in human prostate cancer in vivo. Sufficient conditions for the existence and the stability of a tumour-present equilibrium are given, and the occurrence of a Hopf bifurcation is proven for a uniform delay distribution. Numerical simulations are provided to explore differences in behaviour for uniform and exponential delay distributions. The results suggest that the choice of the delay distribution is key in defining the dynamics of the system and in determining the conditions for the onset of oscillations following a switch in the stability of the tumour-present equilibrium.

Entities:  

Keywords:  androgen deprivation therapy (ADT) ; distributed delay ; dynamical systems ; local asymptotic stability ; prostate cancer ; stability switches

Mesh:

Year:  2021        PMID: 34814314     DOI: 10.3934/mbe.2021425

Source DB:  PubMed          Journal:  Math Biosci Eng        ISSN: 1547-1063            Impact factor:   2.080


  1 in total

1.  High Accuracy Indicators of Androgen Suppression Therapy Failure for Prostate Cancer-A Modeling Study.

Authors:  William Meade; Allison Weber; Tin Phan; Emily Hampston; Laura Figueroa Resa; John Nagy; Yang Kuang
Journal:  Cancers (Basel)       Date:  2022-08-20       Impact factor: 6.575

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.